Reproductive Status Affecting the Incidence of Hypertension in Pregnancy at Prof. Dr. Chairuddin P. Lubis Educational  Hospital, Medan City

Luthfiah Mawar; Rahayu Lubis; Asfriyati Asfriyati; M. Agung Rahmadi; Helsa Nasution

doi:10.62951/ijph.v2i1.300

Authors

Luthfiah Mawar Universitas Sumatera Utara
Rahayu Lubis Universitas Sumatera Utara
Asfriyati Asfriyati Universitas Sumatera Utara
M. Agung Rahmadi Universitas Islam Negeri Syarif Hidayatullah Jakarta
Helsa Nasution Universitas Negeri Padang

DOI:

https://doi.org/10.62951/ijph.v2i1.300

Keywords:

hypertension in pregnancy, maternal age, primigravida, nulliparity, reproductive status, risk predictors

Abstract

Hypertension in pregnancy is one of the leading causes of maternal mortality, with a global prevalence of 5–10% (Khedagi & Bello, 2021). This study aims to analyze the effect of reproductive status—maternal age, gravidity, and parity—on the incidence of hypertension in pregnancy at Prof. Dr. Chairuddin P. Lubis Educational Hospital, Medan. A case-control design was employed with 96 respondents, consisting of 48 cases and 48 controls. Bivariate analysis revealed that pregnant women aged ≥35 years have a 2.839-fold higher risk of developing hypertension compared to those aged <35 years (OR=2.839; 95% CI: 1.123–7.177; p=0.027). First pregnancy (primigravida) increases the risk by 2.742 times compared to multigravida (OR=2.742; 95% CI: 1.047–7.178; p=0.040), while nulliparous women have a 2.714-fold higher risk compared to those who have given birth (OR=2.714; 95% CI: 1.101–6.693; p=0.030). Multivariate analysis identified maternal age ≥35 years and nulliparity as the most significant predictors (p=0.005). These findings align with studies by Wiranto & Putriningtyas (2021), Hinkosa et al. (2020), and Luo et al. (2020), which confirmed that advanced maternal age and nulliparity increase the risk of pregnancy complications. The novelty of this research lies in integrating all three reproductive status factors as simultaneous predictors of hypertension risk, providing a new perspective compared to previous studies focused on single variables. Based on these findings, early detection and targeted health education for high-risk mothers are strongly recommended.

Downloads

Download data is not yet available.

References

Abalos, E., Cuesta, C., Grosso, A. L., Chou, D., & Say, L. (2013). Global and regional estimates of preeclampsia and eclampsia: a systematic review. European journal of obstetrics & gynaecology and reproductive biology, 170(1), 1-7.

Andraweera, P. H., Dekker, G. A., & Roberts, C. T. (2012). The vascular endothelial growth factor family in adverse pregnancy outcomes. Human reproduction update, 18(4), 436-457.

Antwi, E., Amoakoh-Coleman, M., Vieira, D. L., Madhavaram, S., Koram, K. A., Grobbee, D. E., ... & Klipstein-Grobusch, K. (2020). A systematic review of prediction models for gestational hypertension and preeclampsia. PLoS One, 15(4), e0230955.

Arikah, T., Rahardjo, T. B. W., & Widodo, S. (2020). Faktor risiko kejadian hipertensi pada ibu hamil di Puskesmas Kramat Jati Jakarta Timur tahun 2019. Jurnal Penelitian dan Pengembangan Kesehatan Masyarakat Indonesia, 1(2), 115–124.

Aziz, M. A., Wibowo, A., Almira, N. L., & Sutjighassani, T. (2022). Relationship of Age, Body Mass Index, Gravida, and Parity in Pregnant Women with the Incidence Preeclampsia. Indonesian Journal of Obstetrics & Gynecology Science, 5(2), 208–216.

Bartsch, E., Medcalf, K. E., Park, A. L., & Ray, J. G. (2016). Clinical risk factors for preeclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies. Bmj, 353.

Bdolah, Y., Elchalal, U., Natanson-Yaron, S., Yechiam, H., Bdolah-Abram, T., Greenfield, C., Goldman-Wohl, D., Milwidsky, A., Rana, S., Karumanchi, S. A., Yagel, S., & Hochner-Celnikier, D. (2014). The relationship between nulliparity and preeclampsia may be explained by altered circulating soluble fms-like tyrosine kinase 1. Hypertension in Pregnancy, 33(2), 250–259.

Bdolah, Y., Lam, C., Rajakumar, A., Shivalingappa, V., Mutter, W., Sachs, B. P., ... & Karumanchi, S. A. (2009). Twin Pregnancy and the Risk of Preeclampsia: Bigger Placenta or Relative Ischemia? Obstetric Anesthesia Digest, 29(3), 135.

Benschop, L., Duvekot, J. J., & van Lennep, J. E. R. (2019). Future risk of cardiovascular disease risk factors and events in women after a hypertensive disorder of pregnancy. Heart, 105(16), 1273-1278.

Burton, G. J., Redman, C. W., Roberts, J. M., & Moffett, A. (2019). Preeclampsia: pathophysiology and clinical implications. Bmj, 366.

Carpentier, C., Guerby, P., Camiré, B., Tapp, S., Boutin, A., & Bujold, E. (2022). Aspirin responsiveness at a dose of 80 mg and its impact on birth weight when used in twin pregnancies: the GAP Pilot Randomized Trial. American Journal of Perinatology, 39(13), 1396-1400.

Chang, K.-J., Seow, K.-M., & Chen, K.-H. (2023). Preeclampsia: Recent advances in predicting, preventing, and managing the maternal and fetal life-threatening condition. International Journal of Environmental Research and Public Health, 20(4), 2994.

Chappell, L. C., Cluver, C. A., & Tong, S. (2021). Preeclampsia. The Lancet, 398(10297), 341-354.

Dai, J., Shi, Y., Wu, Y., Guo, L., Lu, D., Chen, Y., Wang, Y., Lai, H., & Kong, X. (2023). The interaction between age and parity on adverse pregnancy and neonatal outcomes. Frontiers in Medicine, 10(February), 1–13.

Dewi, I. S., Rahmadi, M. A., Nasution, H., Mawar, L., & Sari, M. (2024). Kepuasan Hidup dan Pengaruhnya Terhadap Keberhasilan Pengobatan Penyakit Lupus. Jurnal Ventilator, 2(3), 300-322.

Duley, L., Meher, S., Hunter, K. E., Seidler, A. L., & Askie, L. M. (2019). Antiplatelet agents for preventing preeclampsia and its complications. Cochrane database of systematic reviews, (10).

English, F. A., Kenny, L. C., & McCarthy, F. P. (2015). Risk factors and effective management of preeclampsia. Integrated blood pressure control, 7–12.

Febyan, & Pemaron, I. B. R. (2020). Tinjauan faktor risiko kejadian hipertensi dalam kehamilan di Rumah Sakit Bhayangkara Denpasar. Indonesian Journal of Obstetrics & Gynecology Science, 3(1), 21–26.

Fox, R., Kitt, J., Leeson, P., Aye, C. Y., & Lewandowski, A. J. (2019). Preeclampsia: risk factors, diagnosis, management, and the cardiovascular impact on the offspring. Journal of Clinical Medicine, 8(10), 1625.

Garovic, V. D., Dechend, R., Easterling, T., Karumanchi, S. A., McMurtry Baird, S., Magee, L. A., ... & August, P. (2022). Hypertension in pregnancy: diagnosis, blood pressure goals, and pharmacotherapy: a scientific statement from the American Heart Association. Hypertension, 79(2), e21-e41.

Haile, T. G., Assefa, N., Alemayehu, T., Mariye, T., Geberemeskel, G. G., Bahrey, D., Mebrahtom, G., Demisse, B., Gebrekidan, H., & Getachew, T. (2021). Determinants of preeclampsia among women attending delivery services in Public Hospitals of Central Tigray, Northern Ethiopia: A case-control study. Journal of Pregnancy, 2021, 1–8.

Harris, J. M., Franck, L., Green, B., & Michie, S. (2014). The psychological impact of providing women with risk information for preeclampsia: a qualitative study. Midwifery, 30(12), 1187-1195.

Harris, K., Xu, L., Woodward, M., De Kat, A., Zhou, X., Shang, J., Hirst, J. E., & Henry, A. (2024). Early pregnancy maternal blood pressure and risk of preeclampsia: Does the association differ by parity? Evidence from 14,086 women across 7 countries. Pregnancy Hypertension, 37(2024), 101136.

Hinkosa, L., Tamene, A., & Gebeyehu, N. (2020). Risk factors associated with hypertensive disorders in pregnancy in Nekemte referral Hospital, from July 2015 to June 2017, Ethiopia: case control study. BMC Pregnancy and Childbirth, 20(16), 1–9.

Jeyabalan, A. (2023). Epidemiology of preeclampsia: impact of obesity. Nutrition Reviews, 71(suppl_1), S18-S25.

Kemenkes RI. (2023). Profil Kesehatan Indonesia 2022.

Kemenkes RI. (2024). Profil Kesehatan Indonesia 2023.

Khaliq, O. P., Konoshita, T., Moodley, J., & Naicker, T. (2020). The role of LNPEP and ANPEP gene polymorphisms in the pathogenesis of preeclampsia. European Journal of Obstetrics & Gynecology and Reproductive Biology, 252, 160–165.

Khedagi, A. M., & Bello, N. A. (2021). Hypertensive disorders of pregnancy. Cardiology Clinics, 39(1), 77–90.

Komladzah, E. (2021). Maternal and Perinatal Outcomes Among Pregnant Women with Hypertensive Disorders in the Volta Region (Doctoral dissertation, University of Cape Coast).

Lemeshow, S., Jr, D. W. H., Klar, J., & Lwanga, S. K. (1990). Adequacy of sample size in health studies. John Wiley & Sons Ltd.

Li, C., Luo, J., Yang, Y., Wang, Q., Zheng, Y., & Zhong, Z. (2023). The relationship between cadmium exposure and preeclampsia: a systematic review and meta-analysis. Frontiers in Medicine, 10, 1259680.

Lokki, A. I., Heikkinen-Eloranta, J. K., & Laivuori, H. (2018). The immunogenetic conundrum of preeclampsia. Frontiers in Immunology, 9(NOV), 1–8.

Lopian, M., Kashani-Ligumsky, L., & Many, A. (2023). A balancing act: Navigating hypertensive disorders of pregnancy at very advanced maternal age, from preconception to postpartum. Journal of Clinical Medicine, 12(14), 4701.

Luo, J., Fan, C., Luo, M., Fang, J., Zhou, S., & Zhang, F. (2020). Pregnancy complications among nulliparous and multiparous women with advanced maternal age: a community-based prospective cohort study in China. BMC Pregnancy and Childbirth, 20(1), 581.

Luo, Z. C., An, N., Xu, H. R., Larante, A., Audibert, F., & Fraser, W. D. (2007). The effects and mechanisms of primiparity on the risk of preeclampsia: a systematic review. Paediatric and perinatal epidemiology, 21, 36-45.

Magee, L. A., Pels, A., Helewa, M., Rey, E., & von Dadelszen, P. (2014). Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health, 4(2), 105-145.

Mawar, L., Rahmadi, M. A., Nasution, H., & Sari, M. (2024). Efek Kecemasan Sosial pada Pengobatan Penyakit Behçet. Vitalitas Medis: Jurnal Kesehatan dan Kedokteran, 1(4), 198-221.

Mawar, L., Rahmadi, M. A., Nasution, H., & Sari, M. (2024). Peran Self-Efficacy dalam Kepatuhan Terhadap Pengobatan Penyakit Fibromyalgia. OBAT: Jurnal Riset Ilmu Farmasi dan Kesehatan, 2(5), 363-385.

Mawar, L., Rahmadi, M. A., Nasution, H., Dewi, I. S., & Sari, M. (2024). Pengaruh Emosi Positif Terhadap Hasil Pengobatan Penyakit Rheumatoid Arthritis. Jurnal Ventilator, 2(3), 352-374.

Mawar, L., Rahmadi, M. A., Nasution, H., Dewi, I. S., Nasution, R., & Sari, M. (2024). Efek Stres terhadap Pengobatan Asthma. Termometer: Jurnal Ilmiah Ilmu Kesehatan dan Kedokteran, 2(4), 86-112.

Mawar, L., Rahmadi, M. A., Nasution, H., Sihombing, N., Nasution, R., & Sari, M. (2024). Peran Kecerdasan Emosional dalam Pengobatan Cystic fibrosis. Detector: Jurnal Inovasi Riset Ilmu Kesehatan, 2(4), 60-90.

McCarthy, J., & Maine, D. (1992). A Framework for Analyzing the Determinants of Maternal Mortality. Studies in Family Planning, 23(1), 23.

McClure, E. M., Garces, A. L., Hibberd, P. L., Moore, J. L., Goudar, S. S., Saleem, S., ... & Goldenberg, R. L. (2020). The Global Network Maternal Newborn Health Registry: a multi-country, community-based registry of pregnancy outcomes. Reproductive health, 17, 1-11.

Muti, M., Tshimanga, M., Notion, G. T., Bangure, D., & Chonzi, P. (2015). Prevalence of pregnancy-induced hypertension and pregnancy outcomes among women seeking maternity services in Harare, Zimbabwe. BMC Cardiovascular Disorders, 15, 1-8.

Nasution, H., Rahmadi, M. A., Mawar, L., & Sari, M. (2024). Efek Depresi terhadap Efektivitas Pengobatan Penyakit Crohn. Jurnal Ventilator, 2(3), 240-260.

Nasution, H., Rahmadi, M. A., Mawar, L., & Sari, M. (2024). Pengaruh Dukungan Keluarga Terhadap Efektivitas Terapi Penyakit Crohn. Jurnal Anestesi, 2(4), 356-381.

Nasution, H., Rahmadi, M. A., Mawar, L., Dewi, I. S., & Sari, M. (2024). Efek Emosi Negatif pada Pengobatan Penyakit Endometriosis. Observasi: Jurnal Publikasi Ilmu Psikologi, 2(4), 218-244.

Nasution, H., Rahmadi, M. A., Mawar, L., Dewi, I. S., Nasution, R., & Sari, M. (2024). Peran Kepuasan Hidup dalam Pengelolaan Penyakit Systemic Sclerosis. Termometer: Jurnal Ilmiah Ilmu Kesehatan dan Kedokteran, 2(4), 195-224.

Nasution, H., Rahmadi, M. A., Mawar, L., Sihombing, N., Nasution, R., & Sari, M. (2024). Hubungan Dukungan Sosial dalam Pengobatan Sklerosis Multipel. Detector: Jurnal Inovasi Riset Ilmu Kesehatan, 2(4), 121-151.

Nasution, R., Rahmadi, M. A., Nasution, H., Mawar, L., Dewi, I. S., & Sari, M. (2024). Pengaruh Intervensi Emosi Positif pada Pengobatan Fibromyalgia. Termometer: Jurnal Ilmiah Ilmu Kesehatan dan Kedokteran, 2(4), 277-302.

Nasution, R., Rahmadi, M. A., Nasution, H., Mawar, L., Dewi, I. S., & Sari, M. (2024). Hubungan antara Perasaan Bersalah dan Keberhasilan Pengobatan Lupus. An-Najat, 2(4), 179-206.

Nobles, C. J., Mendola, P., Mumford, S. L., Naimi, A. I., Yeung, E. H., Kim, K., ... & Schisterman, E. F. (2018). Preconception blood pressure levels and reproductive outcomes in a prospective cohort of women attempting pregnancy. Hypertension, 71(5), 904-910.

Phipps, E. A., Thadhani, R., Benzing, T., & Karumanchi, S. A. (2019). Preeclampsia: pathogenesis, novel diagnostics and therapies. Nature Reviews Nephrology, 15(5), 275–289.

Phipps, E., Prasanna, D., Brima, W., & Jim, B. (2016). Preeclampsia: updates in pathogenesis, definitions, and guidelines. Clinical Journal of the American Society of Nephrology, 11(6), 1102-1113.

Rahmadi, M. A., Nasution, H., Mawa, L., Nasution, R., & Sari, M. (2024). Peran Harapan dalam Kepatuhan Pengobatan Kanker Kolorektal. OBAT: Jurnal Riset Ilmu Farmasi dan Kesehatan, 2(6), 38-64.

Rahmadi, M. A., Nasution, H., Mawar, L., & Sari, M. (2024). Pengaruh Kecemasan Terhadap Kepatuhan Pengobatan Kanker Payudara. Jurnal Medika Nusantara, 2(3), 325-350.

Rahmadi, M. A., Nasution, H., Mawar, L., Dewi, I. S., & Sari, M. (2024). Peran Motivasi Internal dalam Pengobatan Penyakit Fibromyalgia. Jurnal Anestesi, 2(4), 257-283.

Rahmadi, M. A., Nasution, H., Mawar, L., Dewi, I. S., Nasution, R., & Sari, M. (2024). Hubungan Motivasi terhadap Keberhasilan Pengobatan Endometriosis. Termometer: Jurnal Ilmiah Ilmu Kesehatan dan Kedokteran, 2(4), 225-253.

Rana, S., Lemoine, E., Granger, J. P., & Karumanchi, S. A. (2019). Preeclampsia: pathophysiology, challenges, and perspectives. Circulation Research, 124(7), 1094-1112.

Roberts, J. M., & Cooper, D. W. (2001). Pathogenesis and genetics of preeclampsia. The Lancet, 357(9249), 53–56.

Rurangirwa, A. A., Gaillard, R., Steegers, E. A. P., Hofman, A., & Jaddoe, V. W. V. (2012). Hemodynamic adaptations in different trimesters among nulliparous and multiparous pregnant women; the generation R study. American Journal of Hypertension, 25(8), 892–899.

Sava, R. I., March, K. L., & Pepine, C. J. (2018). Hypertension in pregnancy: Taking cues from pathophysiology for clinical practice. Clinical cardiology, 41(2), 220–227.

Sibai, B., Dekker, G., & Kupferminc, M. (2005). Preeclampsia. The Lancet, 365(9461), 785-799.

Steegers, E. A., Von Dadelszen, P., Duvekot, J. J., & Pijnenborg, R. (2010). Preeclampsia. The Lancet, 376(9741), 631-644.

Teirilä, L., Heikkinen-Eloranta, J., Kotimaa, J., Meri, S., & Lokki, A. I. (2019). Regulation of the complement system and immunological tolerance in pregnancy. Seminars in immunology, 45, 101337.

Tesfa, E., Nibret, E., Gizaw, S. T., Zenebe, Y., Mekonnen, Z., Assefa, S., ... & Munshea, A. (2020). Prevalence and determinants of hypertensive disorders of pregnancy in Ethiopia: A systematic review and meta-analysis. PLoS One, 15(9), e0239048.

Thilaganathan, B., & Kalafat, E. (2019). Cardiovascular system in preeclampsia and beyond. Hypertension, 73(3), 522-531.

Upadya, M., & Rao, S. (2018). Hypertensive disorders in pregnancy. Indian Journal of Anaesthesia, 62(9), 675–681.

Valensise, H., Vasapollo, B., Gagliardi, G., & Novelli, G. P. (2008). Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease. Hypertension, 52(5), 873-880.

Wang, W., Xie, X., Yuan, T., Wang, Y., Zhao, F., Zhou, Z., & Zhang, H. (2021). Epidemiological trends of maternal hypertensive disorders of pregnancy at the global, regional, and national levels: a population‐based study. BMC Pregnancy and Childbirth, 21(1), 1–10.

Wang, Y. A., Chughtai, A. A., Farquhar, C. M., Pollock, W., Lui, K., & Sullivan, E. A. (2016). Increased incidence of gestational hypertension and preeclampsia after assisted reproductive technology treatment. Fertility and sterility, 105(4), 920–926.

Webster, K., Fishburn, S., Maresh, M., Findlay, S. C., & Chappell, L. C. (2019). Diagnosis and management of hypertension in pregnancy: summary of updated NICE guidance. Bmj, 366.

WHO. (2023a). Targets of Sustainable Development Goal 3.

WHO. (2023b). Trends in maternal mortality 2000 to 2020: estimates by WHO, UNICEF, UNFPA, World Bank Group and UNDESA/Population Division.

WHO. (2024). Maternal Mortality.

Wiranto, & Putriningtyas, N. D. (2021). Faktor risiko kejadian hipertensi pada ibu hamil. Indonesian Journal of Public Health and Nutrition, 1(3), 759–767.

Wu, P., Haththotuwa, R., Kwok, C. S., Babu, A., Kotronias, R. A., Rushton, C., ... & Mamas, M. A. (2017). Preeclampsia and future cardiovascular health: a systematic review and meta-analysis. Circulation: Cardiovascular Quality and Outcomes, 10(2), e003497.

Xiang, C., Sui, L., Ding, X., Cao, M., Li, G., & Du, Z. (2024). Maternal adiposity measures and hypertensive disorders of pregnancy: a meta-analysis. BMC Pregnancy and Childbirth, 24(1), 675.